Cellebrite DI Ltd.
CLBT
$11.05
-$0.22-1.95%
| Weiss Ratings | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.71 | |||
| Price History | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.87% | |||
| 30-Day Total Return | 2.36% | |||
| 60-Day Total Return | 4.93% | |||
| 90-Day Total Return | 37.44% | |||
| Year to Date Total Return | 33.69% | |||
| 1-Year Total Return | 100.89% | |||
| 2-Year Total Return | 138.27% | |||
| 3-Year Total Return | 13.84% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -11.60% | |||
| 52-Week Low % Change | 111.69% | |||
| Price | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $12.50 | |||
| 52-Week Low Price | $5.22 | |||
| 52-Week Low Price (Date) | May 18, 2023 | |||
| 52-Week High Price (Date) | Mar 04, 2024 | |||
| Valuation | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.31B | |||
| Enterprise Value | 2.00B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.24 | |||
| Earnings Per Share Growth | -141.85% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 13.42 | |||
| Price/Book (Q) | 66.92 | |||
| Enterprise Value/Revenue (TTM) | 11.95 | |||
| Price | $11.27 | |||
| Enterprise Value/EBITDA (TTM) | 74.73 | |||
| Enterprise Value/EBIT | 95.51 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 194.44M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 972 73 394 8000 | |||
| Address | -- | |||
| Website | www.cellebrite.com | |||
| Country | Israel | |||
| Year Founded | 1999 | |||
| Profitability | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $0.84 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | 68.16% | |||
| Earnings Growth (Q YOY) | -306.94% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -727.13% | |||
| Balance Sheet | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 302.92M | |||
| Cash Per Share (Q) | $1.56 | |||
| Total Current Assets (Q) | 422.08M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 34.21M | |||
| Current Ratio (Q) | 1.663 | |||
| Book Value Per Share (Q) | $0.17 | |||
| Total Assets (Q) | 532.89M | |||
| Total Current Liabilities (Q) | 253.82M | |||
| Total Debt (Q) | 14.13M | |||
| Total Liabilities (Q) | 498.67M | |||
| Total Common Equity (Q) | 34.21M | |||
| Cash Flow | CLBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
